Study on the Efficacy and Safety of Bencycloquidium Bromide Nasal Spray Alone or in Combination With Mometasone Furoate Aqueous Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis
Latest Information Update: 07 Mar 2024
At a glance
- Drugs Bencycloquidium bromide (Primary) ; Mometasone (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions
- Sponsors Yingu Pharmaceutical
- 29 Feb 2024 Planned End Date changed from 28 Feb 2022 to 30 Jun 2024.
- 29 Feb 2024 Planned primary completion date changed from 31 Dec 2021 to 30 Apr 2024.
- 29 Feb 2024 Status changed from recruiting to active, no longer recruiting.